Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Clinical trial NCT00707889 · COMPLETED

Trial details

NCT number: NCT00707889
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Colorectal Cancer Adenocarcinoma of the Colon Adenocarcinoma of the Rectum

Start date: 2008-10-01
Primary completion: 2012-05-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.